Literature DB >> 17003779

Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives.

A Cassidy1, J P Myles, S W Duffy, T Liloglou, J K Field.   

Abstract

To investigate the little known risk of lung cancer at an early age when a first-degree relative has had such a diagnosis, 579 incident cases and 1157 population controls were studied in Liverpool between 1998 and 2004 using standardised questionnaires covering demography and lifestyle. A history of lung cancer in first-degree relatives was associated with a significantly increased risk in the proband where in both individuals the cancers were diagnosed before the age of 60 years (odds ratio (OR)=4.89; 95% confidence interval (CI): 1.47-16.25). A significantly elevated risk of lung cancer was also observed in association with a relative affected before the age of 60 years, regardless of age-at-onset of the disease (OR=2.08; 95% CI: 1.20-3.59). This finding is strongly consistent with a genetic component in early-onset lung cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003779      PMCID: PMC2360569          DOI: 10.1038/sj.bjc.6603386

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Smoking is well established as the major aetiological risk factor for lung cancer. Investigators have long hypothesised that individuals differ in their susceptibility to environmental insults and that these differences may be the result of genetic predisposition (Schwartz, 2004). Familial aggregation and increased familial risk for lung cancer have been reported in several studies, providing indirect evidence that genetic factors contribute to susceptibility to lung cancer (Yang ; Etzel ; Matakidou ; Xu ). Recently, a major lung cancer susceptibility locus was mapped to chromosome 6q23–35 through a genome-wide linkage analysis, further supporting the role of genetic factors in the susceptibility of lung cancer (Bailey-Wilson ). Biological theory and the experience of other cancers, including breast (Hopper ), pancreas (James ) and colon (Strate and Syngal, 2005), suggest that tumours associated with genetic factors tend to occur early in life. Numerous lung cancer studies have investigated the numbers of affected relatives and age-at-onset, with greatest risk seen in families with early-onset lung cancer compared with those whose onset of lung cancer occurred at older ages (Kreuzer ; Bromen ; Gauderman and Morrison 2000; Li and Hemminki, 2004; Cote ). However, information on familial risk by age-at-onset of both the proband and the affected relatives is rare in lung cancer studies. Here we report results for a case–control study that examines age-at-onset in both lung cancer cases and affected relatives.

MATERIALS AND METHODS

The lung cancer case–control data were derived from an ongoing molecular–epidemiological study of lung cancer in Liverpool, UK, The Liverpool Lung Project (Field ). Histologically or cytologically confirmed lung cancer cases with primary tumours, resident within the study area, were recruited from participating chest clinics. Population controls were selected from registers of general practitioners in Liverpool and matched to cases by 2-year age group and gender. A standardised questionnaire was used to determine basic demographic characteristics in addition to details on smoking history, family history of cancer in first-degree relatives and exposure to environmental tobacco smoke (ETS). Lifetime smoking histories were recorded, covering: (i) ever smoked (never-smoker defined as someone who had smoked less than 100 cigarettes in his or her lifetime); (ii) current smoker (yes or no); (iii) duration of smoking (years); (iv) pack-years (calculated from the number of cigarette packs (of 20) smoked per day and years of smoking); and (v) amount smoked (average number of cigarettes per day). Environmental tobacco smoke exposure was defined as being in the presence of a smoker on a regular basis. Exposures to ETS at home, work and in public places (e.g. bars) were recorded separately. Information on history of cancer among first-degree relatives (i.e. parents, brothers and sisters and biological children) were recorded, including age-at-diagnosis, site of cancer and relation to the participant. These data were not validated by death certificate, and smoking information of relatives was not obtained. Individuals were defined as having a history of familial lung cancer if at least one relative with lung cancer was reported. The study protocol was approved by the Liverpool Research Ethic Committee and all research participants provided written, informed consent in accordance with the Declaration of Helsinki Principle.

Statistical analyses

Significance tests for differences in distributions between cases and controls, odds ratio (OR) estimates of relative risk and 95% confidence intervals (CI) were all estimated using conditional logistic regression. Early- and late-onset lung cancers were defined as before the age of 60 years and at the age of 60 years or later, respectively, in accordance with the average age of lung cancer diagnoses in our study population. To determine whether the risk of developing lung cancer is greater for relatives of cases with early- and late-onset lung cancer, we performed analyses stratified for (i) cases diagnosed before the age of 60 years and at the age of 60 years or later; and (ii) first-degree relatives diagnosed with lung cancer before the age of 60 years and at the age of 60 years or later. Models were adjusted for smoking duration (five categories), ETS exposure at home, work and in public (two categories) and socioeconomic status (six categories). All analyses were performed using STATA.

RESULTS

Five hundred and seventy-nine incident cases of lung cancer and 1157 population controls were recruited between 1998 and 2004. Overall, the response rate was 58.3% for cases and 61.5% for controls. Table 1 shows the distribution of cases and controls by number of affected relatives, smoking, socioeconomic status and ETS exposure. As expected, the proportion of ever smokers was higher among cases (95.3%) compared with controls (71%), with significant differences observed in terms of duration of smoking (P<0.001). The proportion of cases with two or more first-degree relatives was more than twice that of the controls: 5.2 and 2.3%, respectively (P=0.03). There were also significant differences between cases and controls in socioeconomic status (P<0.001) and exposure to ETS in the home (P<0.001). Borderline significant differences were observed for exposure to ETS at work (P=0.07).
Table 1

Distribution of study-specific characteristics of lung cancer cases and healthy controls, Liverpool, 1998–2004

  Case
Control
 
Variable N % N % P-value *
Number of lung cancer relatives
 045678.894681.80.03
 19316.118315.9 
 2254.3221.7 
 320.450.5 
 430.510.1 
      
Smoking (duration)
 Never274.733529.0<0.001
 1–19 (years)437.423620.4 
 20–39 (years)15727.133729.1 
 40–59 (years)32155.423420.2 
 ⩾60 (years)315.4151.3 
      
Socioeconomic status a
 Managerial and professional7914.427023.5<0.001
 Intermediate occupations498.914112.3 
 Small employers244.4595.1 
 Lower supervisory7313.314512.6 
 Semiroutine and routine28151.142737.2 
 Long term unemployed448.01079.3 
      
Home ETS a
 No10017.336831.8<0.001
 Yes28449.170661.0 
      
Work ETS a
 No14925.737432.30.07
 Yes24642.577667.1 
      
Public ETS a
 No8114.028624.70.16
 Yes30853.286474.7 

ETS=environmental tobacco smoke.

Numbers do not add up to total due to missing data.

P-values were derived from conditional logistic regression.

Although there was a significant trend of increasing risk with numbers of affected relatives (Table 1), there was no significant effect of family history (any vs none) of lung cancer in the study population overall or in late-onset cases, regardless of the age of affected relatives. There was, however, a substantial and statistically significant increase in risk where both the lung cancer case and the affected relative were diagnosed with lung cancer before the age of 60 years (OR=4.89; 95% CI: 1.47, 16.25) (P=0.01). Significantly elevated ORs were also observed in connection with an affected relative diagnosed before the age of 60 years, regardless of age-at-onset of the case (OR=2.08; 95% CI: 1.20, 3.59) (Table 2). The interaction did not reach formal statistical significance (P=0.1).
Table 2

Stratified analyses of early- and late-onset lung cancer in proband and first-degree relatives, Liverpool, 1998–2004

Age of proband Family history of lung cancer Case Control ORa 95% CI P-value*
All agesNo family history4569461.00Reference
 Affected relative <60 years46622.08(1.20–3.59)0.009
 Affected relative ⩾60 years771491.27(0.83–1.95)0.9
       
<60 yearsNo family history972831.00Reference
 Affected relative <60 years15154.89(1.47–16.25)0.01
 Affected relative ⩾60 years14351.37(0.46–4.01)0.6
       
⩾60 yearsNo family history3596631.00Reference
 Affected relative <60 years31471.46(0.75–2.86)0.3
 Affected relative ⩾60 years631141.10(0.68–1.78)0.7

CI=confidence interval; OR=odds ratio.

ORs adjusted for smoking duration, socioeconomic status and ETS (home, work and public).

P-values were derived from conditional logistic regression.

DISCUSSION

Our results demonstrate an approximate five-fold increase in risk of lung cancer in individuals aged less than 60 years if first-degree relatives were diagnosed with early-onset lung cancer (i.e. less than 60 years old). We also found a significantly increased risk associated with family history regardless of age-at-onset. The increase in familial risk reported in younger individuals supports the hypothesis that there is a greater likelihood of a genetic component to risk in this group. Previous studies of familial aggregation suggest that family history of lung cancer among first-degree relatives is associated with increased risk for early-onset, but not late-onset, lung cancer. Kreuzer reported that lung cancer in a first-degree relative was associated with a 2.6-fold increase in risk of lung cancer of young cases (before 46 years of age), with no elevated risk observed in the older group. Bromen reported a 4.75-fold increase in risk of lung cancer among relatives of probands who were diagnosed with lung cancer before the age of 50 years. Li and Hemminki (2004) used a Swedish register of families to estimate standardised incidence ratio for offspring and siblings of cases of lung cancer, and found a substantially increased risk of disease before the age of 50 years in relatives of cases. In an alternative analysis to quantify the lifetime risk of lung cancer in first-degree relatives of early-onset cases diagnosed before the age of 50 years, Cote reported a 1.91-fold increased risk of lung cancer for relatives of early-onset cases compared to affected relatives in a control population. Our results concur with previous reports, but while others have observed age-specific effects in familial lung cancer risk, this is the first study, to our knowledge, demonstrating an increased risk of lung cancer when both the lung cancer case and the affected relative were diagnosed at younger ages. It is difficult for epidemiology to provide conclusive evidence that the accumulation of lung cancer risk has a genetic origin. Cautious interpretation of familial effects on lung cancer risk is therefore required because of the possibility that elevated relative risks are due to shared smoking habits within families (Khoury ). However, it is difficult to envisage how such confounding could be very strong at young ages and almost nonexistent at older. It is therefore likely that our observed additional risk for early onset disease associated with family history is not due to such confounding. Furthermore, a recent segregation analysis of lung cancer pedigrees, allowing for the effects of smoking sex and age, suggests that multiple genetic factors (possibly multiple genetic loci and interactions) contribute to susceptibility and age-of-onset for lung cancer (Xu ). The particularly high risk observed in our study associated with early onset in both the proband and the affected relatives adds to the evidence of a genetic component. In our study, smoking information allowed a detailed adjustment in the analyses. In addition, we controlled for other known environmental factors, such as socioeconomic status and ETS, which have previously been associated with an increased risk of lung cancer. A limitation of the present study pertains to the use of self-reported family history of cancer, which may result in inaccurate risk estimates. Bondy evaluated the validity of proband-reported family history of cancer using medical records and death certificates, noting that 85% of probands correctly identified primary lung cancer in first-degree relatives. However, a recent cancer registry study linking individuals to their first-degree family members suggests that in case–control studies of a specific cancer type, cases are more likely than controls to report both true-positive and false-positive family histories of their particular cancer, resulting in inflated estimates of the relative risk (Chang ). Another limitation of the present study is the possibility of recall bias or other biases in determination of family history in a case–control design (Khoury and Flanders, 1995; Kreuzer ). Furthermore, because the age-at-onset among relatives was reported by the lung cancer case, inaccuracies may lead to information bias. It is unlikely, however, that such biases could lead to effects as substantial and specific as observed in our study. In conclusion, our study found a substantial and significant increase in risk of having lung cancer before the age of 60 years exclusively associated with a relative having also had lung cancer diagnosed before the age of 60 years. This remains significant after adjustment for smoking, socioeconomic status and ETS exposure and is consistent with a genetic component to risk in early-onset lung cancer.
  19 in total

Review 1.  Genetic predisposition to lung cancer.

Authors:  Ann G Schwartz
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

2.  Reliability of self-reported family history of cancer in a large case-control study of lymphoma.

Authors:  Ellen T Chang; Karin Ekström Smedby; Henrik Hjalgrim; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

3.  Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?

Authors:  M J Khoury; T H Beaty; K Y Liang
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

4.  Bias in using family history as a risk factor in case-control studies of disease.

Authors:  M J Khoury; W D Flanders
Journal:  Epidemiology       Date:  1995-09       Impact factor: 4.822

5.  Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.

Authors:  Michele L Coté; Sharon L R Kardia; Angela S Wenzlaff; John C Ruckdeschel; Ann G Schwartz
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis.

Authors:  P Yang; A G Schwartz; A E McAllister; G M Swanson; C E Aston
Journal:  Genet Epidemiol       Date:  1999-11       Impact factor: 2.135

7.  Risk factors associated with earlier age of onset in familial pancreatic carcinoma.

Authors:  Ted A James; David G Sheldon; Ashwani Rajput; Boris W Kuvshinoff; Milind M Javle; Hector R Nava; Judy L Smith; John F Gibbs
Journal:  Cancer       Date:  2004-12-15       Impact factor: 6.860

8.  Inherited predisposition to early onset lung cancer according to histological type.

Authors:  Xinjun Li; Kari Hemminki
Journal:  Int J Cancer       Date:  2004-11-10       Impact factor: 7.396

9.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

10.  Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma.

Authors:  M L Bondy; S S Strom; M W Colopy; B W Brown; L C Strong
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

View more
  10 in total

Review 1.  [Systematic review of the relationship between family history of lung cancer and lung cancer risk].

Authors:  Jundong Gu; Feng Hua; Diansheng Zhong; Jun Chen; Hongyu Liu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-03

2.  First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?

Authors:  Ricardo Marcos-Pinto; Mário Dinis-Ribeiro; Fátima Carneiro; José Carlos Machado; Ceu Figueiredo; Celso A Reis; José Ferreira; Jorge Areias
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

3.  Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals.

Authors:  Esther H Lips; Valerie Gaborieau; James D McKay; Amelie Chabrier; Rayjean J Hung; Paolo Boffetta; Mia Hashibe; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; John K Field; Triantafillos Liloglou; George Xinarianos; John McLaughlin; Geoffrey Liu; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Epic Study; Simone Benhamou; Pagona Lagiou; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Xavier Castellsagué; Tatiana V Macfarlane; Luigi Barzan; Cristina Canova; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Maria Paula Curado; Sergio Koifman; Jose Eluf-Neto; Elena Matos; Ana Menezes; Leticia Fernandez; Andres Metspalu; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

4.  Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer.

Authors:  Ying Gao; Alisa M Goldstein; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Margaret A Tucker; Neil E Caporaso; Lynn Goldin; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

5.  Age of onset in familial cancer.

Authors:  A Brandt; J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Ann Oncol       Date:  2008-07-24       Impact factor: 32.976

6.  Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.

Authors:  Albert Rosenberger; Melanie Sohns; Stefanie Friedrichs; Rayjean J Hung; Gord Fehringer; John McLaughlin; Christopher I Amos; Paul Brennan; Angela Risch; Irene Brüske; Neil E Caporaso; Maria Teresa Landi; David C Christiani; Yongyue Wei; Heike Bickeböller
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

7.  Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival.

Authors:  Anna May Suidan; Laila Roisman; Anna Belilovski Rozenblum; Maya Ilouze; Elizabeth Dudnik; Alona Zer; Nir Peled
Journal:  J Glob Oncol       Date:  2019-05

8.  Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.

Authors:  Rudolf M Huber; Milena Cavic; Anna Kerpel-Fronius; Lucia Viola; John Field; Long Jiang; Ella A Kazerooni; Coenraad F N Koegelenberg; Anant Mohan; Ricardo Sales Dos Santos; Luigi Ventura; Murry Wynes; Dawei Yang; Javier Zulueta; Choon-Taek Lee; Martin C Tammemägi; Claudia I Henschke; Stephen Lam
Journal:  J Thorac Oncol       Date:  2021-12-03       Impact factor: 15.609

9.  Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study.

Authors:  Wenbin Zhou; Qiang Ding; Hong Pan; Naping Wu; Mengdi Liang; Yaoyu Huang; Lin Chen; Xiaoming Zha; Xiaoan Liu; Shui Wang
Journal:  BMC Cancer       Date:  2014-09-11       Impact factor: 4.430

10.  The LLP risk model: an individual risk prediction model for lung cancer.

Authors:  A Cassidy; J P Myles; M van Tongeren; R D Page; T Liloglou; S W Duffy; J K Field
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.